Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben is 2N Pharma’s co-founder and CEO and brings broad business and finance experience from an international career spanning nine countries over 25 years. He is co-founder of clinical-stage vaccine company 2A Pharma, and chairman of Apoglyx, a Swedish biotech...
John Nieland, PhD

John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and a strong scientific background. He was previously director of research at Medigene AG. Next, he is co-founder of the clinical-stage vaccine company 2A Pharma. In addition to...
Anne Skøttrup Mørkholt, PhD

Anne Skøttrup Mørkholt, PhD

Anne completed her doctorate at the Laboratory of Metabolism Modifying Medicine, Aalborg University. She researched the connection between dysfunction of the lipid metabolism and CNS diseases, including multiple sclerosis and depression.
Thomas Brimert, PhD

Thomas Brimert, PhD

Co-founder of Red Glead Discovery – a pre-clinical drug discovery CRO. Thomas Brimert is a skilled organic and medicinal chemist with over 20 years of experience. After a post-doc at the University of Odense in Denmark, he joined AstraZeneca R&D Lund as a Senior...